Kyntra Bio Inc

KYNB

Healthcare Biotechnology

Kyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.

Revenue
n/m
EPS
n/m
Free cash flow
n/m

Quarter to June 2026, against a year earlier

3.44 0.15 −4.18%
Market cap
$14.5M
P/E
0.1×
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
5/9
ROIC
0.00%
Net debt / EBITDA
2.0×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2025, 31 December 2025

Debt has fallen from $97.4M to $71.9M since FY16. Liabilities are $17.0M more than assets: shareholders’ equity is negative. What is a balance sheet?

31 December 2025 · total $119.6M

Owns

$361.0KLong-term assets
$10.1MOther short-term assets
$109.1MCash & all investments

Funded by

$136.6MOther liabilities

Debt is 0.0% of the total; liabilities are $17.0M more than assets.

Net cash fell from 48% of assets to 32% since FY16.

Assets and net debt, eight yearsTotal assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, eight years
FY16FY17FY18FY19FY20FY21FY22FY23
Total assets$0.5B$0.9B$0.9B$0.9B$0.8B$0.8B$0.6B$0.4B
Net debt (debt less cash)−$0.2B−$0.6B−$0.6B−$0.6B−$0.7B−$0.5B−$0.3B−$0.1B
Net debt ÷ assets (right axis)−48.3%−72.2%−64.6%−65.0%−80.3%−60.8%−54.9%−32.3%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
88.98 50.48 203.45 422.01 405.19 686.54 533.76 621.40 735.72 253.18
Receivables
0.22 0.48 5.12 16.30 17.40 41.88 28.46 63.68 8.45 10.45
Inventory
3.74 3.16 17.17 40.44 31.02 16.53 6.89 — — —
Other current assets
— 110.85 65.78 14.08 12.45 10.16 8.18 4.93 4.80 2.89
Total current assets
99.07 196.51 331.56 492.83 474.06 755.11 702.49 690.02 748.97 266.52
Property, Plant, Equpment (Net)
— — 4.79 20.61 28.28 33.65 42.74 127.20 129.48 123.66
Long-Term Investments
20.16 — 5.29 9.41 171.62 2.97 61.12 55.82 10.51 71.01
Long-term assets (Other)
0.36 18.02 22.25 7.35 8.75 3.46 11.44 7.57 9.70 8.37
Total non-current assets
20.52 18.02 91.97 117.26 299.76 71.73 154.91 190.58 149.68 203.04
Total Assets
119.59 214.53 423.53 610.09 773.82 826.84 857.40 880.60 898.65 469.55
Accounts Payable
3.75 5.06 15.78 30.76 26.10 24.79 6.09 9.14 5.51 6.22
Accrued Expenses
20.18 62.04 132.99 219.77 172.60 118.33 83.82 66.12 63.78 50.91
Current Part of Capital Lease
— — — — 0.01 12.33 12.35 — — —
Current Revenue (Deferred)
5.31 27.29 12.74 12.74 15.86 6.55 0.49 13.77 16.67 7.99
Other current liabilities
— 38.92 43.52 232.48 188.45 124.88 83.32 79.89 80.45 58.90
Total current liabilities
29.24 133.31 217.67 273.56 225.50 163.19 102.75 89.03 85.96 65.13
Long Term Debt (Total)
— 73.09 71.93 96.65 106.39 25.39 37.61 107.96 97.76 97.35
Non-current Revenue (Deferred)
0.26 114.71 157.56 185.72 186.80 138.47 99.45 139.15 141.90 110.92
Minority Interests
21.48 21.48 21.48 — — — — — — —
Non-current Liabilities (Other)
85.62 77.05 73.54 72.69 43.63 57.49 82.19 26.79 25.29 21.05
Total non-current liabilities
107.36 286.33 389.54 338.01 319.21 222.20 219.25 263.10 264.95 229.32
Total liabilities
136.60 419.64 607.21 611.57 544.71 385.39 321.99 352.13 350.91 294.44
Additional Paid In Capital
1,677.18 1,668.62 1,643.64 1,541.02 1,476.41 1,399.77 1,300.73 1,226.45 1,160.09 625.90
Common Stock (Net)
1.01 1.01 0.99 0.94 0.93 0.91 0.88 0.85 0.83 0.64
Retained Earnings
(1,706.05) (1,889.50) (1,841.92) (1,557.69) (1,264.03) (974.01) (784.72) (715.83) (630.66) (469.74)
Common Equity (Total)
(17.01) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Shareholders Equity (Total)
(17.00) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Shareholders Equity and Liabilities (Total)
119.59 214.53 423.53 610.09 773.82 826.84 857.40 880.60 898.65 469.55
Shares (Common)
4.05 4.04 3.95 3.77 3.72 3.66 3.51 3.42 3.30 2.55
Shareholders Equity (Tangible)
(17.00) (205.11) (183.68) (1.48) 229.11 441.45 535.41 528.47 547.74 175.11
Net Debt
(88.98) 22.61 (131.52) (325.36) (298.80) (661.15) (496.15) (513.45) (637.95) (155.83)
Total Debt
— 73.09 71.93 96.65 106.39 25.39 37.61 107.96 97.76 97.35

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 25 Oct 2026